Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Kim

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Nature Medicine|March 8, 2006
Reply to 'Truth in numbers'Peter S Kim
Current Opinion in Immunology|March 9, 2010
Features of responding T cells in cancer and chronic infectionPeter S Kim, Rafi Ahmed
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Toward development of a screen to identify randomly encoded, foldable sequencesYoshihisa Hagihara, Peter S Kim
The New England Journal of Medicine|May 13, 2011
More on DSMBsMichael Rosenblatt, Peter S Kim
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2019
A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discoveryShaogeng Tang, Peter S Kim
Oncoimmunology|August 2, 2014
Potential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapyPeter S Kim, Jeffrey Schlom
Journal of the International AIDS Society|March 23, 2021
Ending TB: the world's oldest pandemicPeter S Kim, Soumya Swaminathan
Bulletin of Mathematical Biology|September 3, 2021
Mathematical Model for Delayed Responses in Immune Checkpoint BlockadesCollin Y Zheng, Peter S Kim
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitopePayton A Weidenbacher, Peter S Kim
Journal of Theoretical Biology|February 1, 2011
T cell state transition produces an emergent change detectorPeter S Kim, Peter P Lee
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Nature Medicine|March 8, 2006
Reply to 'Truth in numbers'Peter S Kim
Current Opinion in Immunology|March 9, 2010
Features of responding T cells in cancer and chronic infectionPeter S Kim, Rafi Ahmed
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Toward development of a screen to identify randomly encoded, foldable sequencesYoshihisa Hagihara, Peter S Kim
The New England Journal of Medicine|May 13, 2011
More on DSMBsMichael Rosenblatt, Peter S Kim
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2019
A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discoveryShaogeng Tang, Peter S Kim
Oncoimmunology|August 2, 2014
Potential utility of the pan-Bcl-2 inhibitor GX15-070 (obatoclax) in cancer immunotherapyPeter S Kim, Jeffrey Schlom
Journal of the International AIDS Society|March 23, 2021
Ending TB: the world's oldest pandemicPeter S Kim, Soumya Swaminathan
Bulletin of Mathematical Biology|September 3, 2021
Mathematical Model for Delayed Responses in Immune Checkpoint BlockadesCollin Y Zheng, Peter S Kim
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitopePayton A Weidenbacher, Peter S Kim
Journal of Theoretical Biology|February 1, 2011
T cell state transition produces an emergent change detectorPeter S Kim, Peter P Lee
Pageof 19